| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 02/24/1998 | US5721242 Administering a synergistic combination of epiroprim and dapsone |
| 02/24/1998 | US5721241 Enzyme inhibitors, their synthesis, and methods for use |
| 02/24/1998 | US5721237 Administering for the selective treatment of cell growth and differentiation |
| 02/24/1998 | US5721226 Method for inhibiting angiogenesis using squalamine and squalamine steroid derivatives |
| 02/24/1998 | US5720957 Recombinant human cytomegalovirus vaccine |
| 02/24/1998 | US5720304 Diagnosis by conventional medical technique or bi-digital-o-ring test; having patient ingest antibiotic or antiviral agent, also ingest a herb concentration of umbelliferae family over sustained period of time |
| 02/22/1998 | CA2213057A1 An amide derivative of amythiamicin |
| 02/19/1998 | WO1998006844A1 Keratinocyte growth factor-2 (kgf-2 or fibroblast growth factor-12, kgf-12) |
| 02/19/1998 | WO1998006734A1 Novel prokaryotic polynucleotides, polypeptides and their uses |
| 02/19/1998 | WO1998006726A1 Phosphonate nucleotide compounds |
| 02/19/1998 | WO1998006712A1 Neuraminic acid compounds |
| 02/19/1998 | WO1998006692A1 Novel immunotherapeutic agents and their use in the reduction of cytokine levels |
| 02/19/1998 | WO1998006437A2 Compositions and methods for polynucleotide delivery |
| 02/19/1998 | WO1998006432A1 Outer membrane protein b1 of moraxella catarrhalis |
| 02/19/1998 | WO1998006429A1 Hiv p-17 peptide fragment, compositions containing and methods for producing and using same |
| 02/19/1998 | WO1998006425A1 Treatment and prevention of infections, inflammations and/or tumours with lactoferrin and/or lactoferricin |
| 02/19/1998 | WO1998006416A1 Conjugated peptides, immunological reagent containing same and use thereof for treatment of immunological disorders |
| 02/19/1998 | WO1998006415A2 Anti-chlamydial methods and materials |
| 02/19/1998 | WO1998006266A1 Antiviral materials |
| 02/19/1998 | WO1998006265A2 Treatment of fungal infections using a combination of an anti-fungal compound and an n-alkyl-heterocyclic compound, especially n-dodecyl-morpholine |
| 02/19/1998 | WO1998001571A3 Erythromycins and process for their preparation |
| 02/19/1998 | WO1997042979A3 Ethene containing solutions and use thereof in methods of therapy or prophylaxis |
| 02/19/1998 | DE19719522A1 New poly:cyclic phthalazine compounds (madura:phthalazine derivatives) |
| 02/19/1998 | CA2263416A1 Treatment and prevention of infections, inflammations and/or tumours with lactoferrin and/or lactoferricin |
| 02/19/1998 | CA2263286A1 Phosphonate nucleotide compound |
| 02/19/1998 | CA2263143A1 Keratinocyte growth factor-2 (kgf-2 or fibroblast growth factor-12, fgf-12) |
| 02/19/1998 | CA2263077A1 Treatment of fungal infections using a combination of an anti-fungal compound and an n-alkyl-heterocyclic compound |
| 02/19/1998 | CA2262432A1 Hiv p-17 peptide fragment, compositions containing and methods for producing and using same |
| 02/19/1998 | CA2262427A1 Conjugated peptides, immunological reagent containing same and use thereof for treatment of immunological disorders |
| 02/19/1998 | CA2213285A1 Novel polyene antibiotics, 3874 h1 to h6, processes for their preparation and use |
| 02/18/1998 | EP0824213A2 Method for fractionating red blood cells and antibacterial materials or bacterial proliferation inhibitors produced thereby |
| 02/18/1998 | EP0823996A1 Anti-infective against STD relating, for example, to HIV, Chlamydia, gonococcus, treponema pallidum or herpes simplex and device used to preserve/mix principal ingredient and base of such anti-infective |
| 02/18/1998 | EP0823942A1 Efflux pump inhibitors |
| 02/18/1998 | EP0823911A1 Esters of carbapenems |
| 02/18/1998 | EP0823910A1 Esters of carbapenems |
| 02/18/1998 | EP0823893A1 Novel tetracycline derivatives |
| 02/18/1998 | EP0675900B1 Antibiotics ge 37468 a, b and c |
| 02/18/1998 | CN1173897A Eukaryotic initiation factor SA (eif-5A) mutants |
| 02/18/1998 | CN1173877A Novel membrane proteins of helicobacter pylori |
| 02/18/1998 | CN1173876A Novel membrane proteine P76 of helicobacter pylori |
| 02/18/1998 | CN1173875A Process for preparing certain AZA Cyclohexapeptides |
| 02/18/1998 | CN1173820A Pharmaceutical composition for the treatment of herpes |
| 02/18/1998 | CN1173817A Method, compsns and kits for increasing the oral bioavilability of pharmaceuticalagents |
| 02/18/1998 | CN1173328A Use of medicinal feed for systemic treatment of fish diseases |
| 02/18/1998 | CN1037441C Bicyclic amine derivatives and herbicides containing the same |
| 02/17/1998 | US5719287 Intermediates for inhibitors of HIV protease and method of preparation thereof |
| 02/17/1998 | US5719277 Diamine salts of clavulanic acid |
| 02/17/1998 | US5719194 Prevention and treatment of topical viral infections with perfluoropolyethers or compositions thereof |
| 02/17/1998 | US5719192 Orally administering to treat pneumocystis carinii pneumonia |
| 02/17/1998 | US5719189 Containing triphenylmethane |
| 02/17/1998 | US5719154 Treating microbial infections in humans and animals |
| 02/17/1998 | US5719139 9-oxo-1-azabicyclo 5.2.0!non-2,4-diene-2-carboxylic acid compounds as antibiotics |
| 02/17/1998 | US5719129 Sunscreen agents, antiaging agent, free radical scavenger |
| 02/17/1998 | US5719054 Recombinant virus vectors encoding human papillomavirus proteins |
| 02/17/1998 | US5719049 Process for purifying hepatitis A virus (HAV), virus thus purified and vaccine compositions containing it |
| 02/17/1998 | US5719041 DNA encoding ecotin homologs |
| 02/17/1998 | US5718915 Antiviral liposome having coupled target-binding moiety and hydrolytic enzyme |
| 02/17/1998 | US5718900 Vaccines and methods for preventing and treating Fescue toxicosis in herbivores |
| 02/17/1998 | CA2080566C Pharmaceutical compositions containing triazole derivatives for rectal administration |
| 02/15/1998 | CA2209540A1 Anti-infective against std relating, for example, to hiv, chlamydia, gonococcus, treponema pallidum or herpes simplex and device used to preserve/mix principal ingredient and baseof such anti-infective |
| 02/12/1998 | WO1998005784A1 Dna molecule fragments encoding for cellular uptake of mycobacterium tuberculosis and uses thereof |
| 02/12/1998 | WO1998005776A2 Secreted proteins and polynucleotides encoding them |
| 02/12/1998 | WO1998005755A1 Detection, prevention and treatment of papillomatous digital dermatitis |
| 02/12/1998 | WO1998005687A1 Monoclonal antibody which agglutinates e. coli having the cs4-cfa/i family protein |
| 02/12/1998 | WO1998005660A1 Pyrrolo(3,2-c) quinoline derivatives |
| 02/12/1998 | WO1998005659A1 Azabicyclic carbamoyloxy mutilin derivatives for antibacterial use |
| 02/12/1998 | WO1998005654A1 Compounds of the 3-aryl 2,4 dioxo oxazolidine family and use thereof in cosmetics and pharmaceuticals |
| 02/12/1998 | WO1998005361A2 Long-acting drugs and pharmaceutical compositions comprising them |
| 02/12/1998 | WO1998005350A1 Materials and methods for treatment of plaquing diseases |
| 02/12/1998 | WO1998005348A1 Peptides responsive to antibodies against a consensus peptide of the cs4-cfa/i family proteins |
| 02/12/1998 | WO1998005347A1 Compounds that inhibit interaction between signal-transducing proteins and the glgf (pdz/dhr) domain and uses thereof |
| 02/12/1998 | WO1998005341A1 The use of heparin or heparan sulphate in combination with chitosan for the prevention or treatment of infections caused by herpes virus |
| 02/12/1998 | WO1998005336A1 Inhibitors of cysteine protease |
| 02/12/1998 | WO1998005335A1 PURINE INHIBITORS OF CYCLIN DEPENDENT KINASE 2 AND IλB-$g(a) |
| 02/12/1998 | WO1998005317A1 Il-8 receptor antagonists |
| 02/12/1998 | WO1998005313A1 Composition comprising mupirocin and chlorhexidine |
| 02/12/1998 | WO1998005311A1 Use of bronopol for the treatment of diseases in fish |
| 02/12/1998 | WO1998005211A1 Improved method for systemic administration of 2,4-dienoic acid-type insecticides to terrestrial mammals |
| 02/12/1998 | WO1997047271A3 Cellular vaccines and immunotherapeutics and methods for their preparation |
| 02/12/1998 | WO1997045139A3 Il-12 as an adjuvant for bordetella pertussis vaccines |
| 02/12/1998 | WO1997044354A3 Synthesis of soluble beta-sheet forming peptides |
| 02/12/1998 | WO1997034599A3 Use of clotrimazole and related compounds in the treatment of diarrhea |
| 02/12/1998 | CA2262460A1 Azabicyclic carbamoyloxy mutilin derivatives for antibacterial use |
| 02/12/1998 | CA2262430A1 Composition comprising mupirocin and chlorhexidine |
| 02/12/1998 | CA2262415A1 Dna molecule fragments encoding for cellular uptake of mycobacterium tuberculosis and uses thereof |
| 02/12/1998 | CA2262399A1 Secreted proteins and polynucleotides encoding them |
| 02/12/1998 | CA2261742A1 The use of heparin or heparan sulphate in combination with chitosan for the prevention or treatment of infections caused by herpes virus |
| 02/12/1998 | CA2260742A1 Compounds that inhibit interaction between signal-transducing proteins and the glgf (pdz/dhr) domain and uses thereof |
| 02/12/1998 | CA2233987A1 Materials and methods for treatment of plaquing diseases |
| 02/12/1998 | CA2233570A1 Detection, prevention and treatment of papillomatous digital dermatitis |
| 02/11/1998 | EP0823428A2 Neuraminic acid derivatives, their preparation and their medical use |
| 02/11/1998 | EP0823426A1 Xanthene and acridine derivatives and their use |
| 02/11/1998 | EP0823413A2 Benzoheterocyclic compounds |
| 02/11/1998 | EP0822987A2 Polynucleotides and aminoacid sequences from staphylococcus aureus |
| 02/11/1998 | EP0822985A1 Variable fragments of immunoglobulins - use for therapeutic or veterinary purposes |
| 02/11/1998 | EP0822984A1 Human tumor necrosis factor receptors |
| 02/11/1998 | EP0822983A1 Apopain |
| 02/11/1998 | EP0822980A1 Recombinant infectious laryngotracheitis virus and uses thereof |
| 02/11/1998 | EP0822942A1 Modified anti-icam-1 antibodies and their use in the treatment of inflammation |
| 02/11/1998 | EP0822941A1 Monoclonal antibodies against hiv-1 and vaccines made thereof |